Drawing for QDB

USPTO serial 87771736

QDB

Reviewed by CopyMark Law Group

Reg. 6322540Status 700Renewal
Filing date
Status date
Registration date
Apr 13, 2021
Examiner
VOHRA, SANJEEV KUMAR
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with QDB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001[ Diagnostic kits ] consisting primarily of [ monoclonal antibodies, buffers, ] and [ reagents ] to monitor toxicity of drugs; [ diagnostic preparations ] for clinical or medical laboratory use; diagnostic preparations for scientific or research use; diagnostic preparations for scientific use; diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for scientific or research use; diagnostic reagents for scientific use; laboratory chemicals, namely, an [ antibody reagent ] used for the detection of antigens in cell and tissue analysis for [ in vitro diagnostic ] useACTIVESep 4, 2018
005[ Diagnostic agents, preparations and substances for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations for medical purposes; diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; diagnostic reagents for medicinal use; medical diagnostic reagents; reagents and media for medical and veterinary diagnostic purposes ]ACTIVESep 6, 2018
042[ Computer diagnostic services; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; providing a website featuring information about investigational medical devices, diagnostics and drugs; providing medical testing services and information in the field of cancer research and disease classification ]ACTIVESep 6, 2018
044[ Consulting services in the fields of diagnostic medical testing and nutrition; health care services, namely, providing a database in the field of cancer information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals ]ACTIVESep 6, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 2, 2026PR23POST REGISTRATION ACTION MAILED - SEC. 8 & 15—
Sep 2, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 5, 2026E815TEAS SECTION 8 & 15 RECEIVED—
Apr 13, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 13, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 9, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 6, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 4, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 22, 2021IUAFUSE AMENDMENT FILED—
Feb 22, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 19, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 18, 2020EX4GSOU EXTENSION 4 GRANTED—
Aug 20, 2020EXT4SOU EXTENSION 4 FILED—
Aug 20, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 6, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 5, 2020EX3GSOU EXTENSION 3 GRANTED—
Mar 5, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 24, 2020EXT3SOU EXTENSION 3 FILED—
Feb 24, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 24, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 24, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 27, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 24, 2019EX2GSOU EXTENSION 2 GRANTED—
Aug 24, 2019EXT2SOU EXTENSION 2 FILED—
Aug 24, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 28, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 26, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 26, 2019EX1GSOU EXTENSION 1 GRANTED—
Feb 26, 2019EXT1SOU EXTENSION 1 FILED—
Feb 26, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 28, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 3, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 3, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 13, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 17, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 16, 2018XAECEXAMINER'S AMENDMENT ENTERED—
May 16, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 16, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
May 16, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
May 9, 2018DOCKASSIGNED TO EXAMINER—
Feb 8, 2018MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Feb 7, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 30, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance